Epstein-Barr Virus-Induced Infectious Mononucleosis after Two Separate Episodes of Virus-Associated Hemophagocytic Syndrome

被引：0

作者：

Ohno, Tatsuharu ^{[1
]}

Ueda, Yo ^{[1
]}

Kishimoto, Wataru ^{[1
]}

Arimoto-Miyamoto, Kazue ^{[1
]}

Takeoka, Tomoharu ^{[1
]}

Tsuji, Masaaki ^{[1
]}

机构：

[1] Ohtsu Red Cross Hosp, Dept Internal Med, Div Hematol & Immunol, Shiga, Japan

来源：

INTERNAL MEDICINE | 2009年 / 48卷 / 13期

关键词：

Epstein-Barr virus; infectious mononucleosis; hemophagocytic syndrome; virus-associated hemophagocytic syndrome; TREATMENT STRATEGIES; T-CELLS; GENE; LYMPHOHISTIOCYTOSIS; LYMPHOCYTES;

D O I：

10.2169/internalmedicine.48.1634

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 24-year-old man, who had suffered previous two episodes of non-Epstein-Barr virus (EBV)-associated hemophagocytic syndrome (HPS) at the ages of 16 and 18, developed EBV-induced infectious mononucleosis. His antibody pattern to EBV highlighted the initial infection. The disease took a self-limited course without developing into HPS. No reactivation of EBV infection was noted over the following 6 years. The patient may have attained immune competency in adulthood, which was somehow impaired during his adolescence.

引用

页码：1169 / 1173

页数：5

共 18 条

[1] Hemophagocytic syndromes and infection
Fisman, DN
[J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (06) : 601 - 608
[2] Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
Imashuku, S
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (03) : 259 - 272
[3] Treatment strategies for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH)
Imashuku, S
Tabata, Y
Teramura, T
Hibi, S
[J]. LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 37 - 49
[4] Infection- and malignancy-associated hemophagocytic syndromes - Secondary hemophagocytic lymphohistiocytosis
Janka, G
Imashuku, S
Elinder, G
Schneider, M
Henter, JI
[J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) : 435 - +
[5] Hemophagocytic syndromes
Janka, Gritta E.
[J]. BLOOD REVIEWS, 2007, 21 (05) : 245 - 253
[6] Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection
Kasahara, Y
Yachie, A
Takei, K
Kanegane, C
Okada, K
Ohta, K
Seki, H
Igarashi, N
Maruhashi, K
Katayama, K
Katoh, E
Terao, G
Sakiyama, Y
Koizumi, S
[J]. BLOOD, 2001, 98 (06) : 1882 - 1888
[7] Kawa K, 2000, INT J HEMATOL, V71, P108
[8] EPSTEIN-BARR-VIRUS INFECTED T-LYMPHOCYTES IN EPSTEIN-BARR-VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME
KAWAGUCHI, H
MIYASHITA, T
HERBST, H
NIEDOBITEK, G
ASADA, M
TSUCHIDA, M
HANADA, R
KINOSHITA, A
SAKURAI, M
KOBAYASHI, N
MIZUTANI, S
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) : 1444 - 1450
[9] Pathogenesis of hemophagocytic syndrome (HPS)
Larroche, C
Mouthon, L
[J]. AUTOIMMUNITY REVIEWS, 2004, 3 (02) : 159 - 165
[10] Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome
Lay, JD
Tsao, CJ
Chen, JY
Kadin, ME
Su, IJ
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 1969 - 1979

← 1 2 →